Press Release: Perfectus Biomed : Atelerix and Perfectus Biomed Group collaborate to improve the storage of COVID-19 test swabs
London, UK, 22th June 2020 / Sciad Newswire / The UK Innovation and Science Seed Fund (UKI2S) is delighted to announce the collaboration of Atelerix and Perfectus Biomed Group, two of UKI2S's portfolio companies.
Read full article »
Perfectus Biomed is an England-based contract research organization that provides services such as molecular testing and cell banking for the healthcare industry.
Read more